entertainment -WSS

entertainment

author：leisure time 2025-08-11 08:00:59 - browse：25155

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Syphilis numbers in the United States reach record heights

WSS

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

New clues to why women have higher risk of autoimmune disorders

Personalized medicine goes far beyond genetics

Personalized medicine goes far beyond genetics

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Merck CEO won’t testify in Senate, citing no expertise in drug prices

leisure time

entertainment

hotspot

Peter Hotez and the public health issue of online harassment

Reconstructing family trees of blood cells may help predict disease

Medicare details structure of new drug price negotiation program

Health Care Service Corp to buy Cigna Medicare Advantage plans

Walensky prepares to leave CDC — and Congress — behind

The a glaring gap in research on serious mental illness and primary care

Heart attack and stroke risk calculators need revising

CDC recommends RSV monoclonal antibody for infants

Dobbs anniversary: the lost opportunity of abortion as health care

How I helped Pfizer think through the ethics of Viagra

Wikipedia

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Pharma showers House GOP doctor with campaign cash

The cancer stories no one wants to hear

Late stage cancers on the rise after pandemic delayed screenings

The a glaring gap in research on serious mental illness and primary care

Chris Christie meets with Zelenskyy during Ukraine trip

focus

focus

focus

focus